- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 42.72 | 18.44 | 81.25 | 0.95 | 2.15 | -12.84 | 1.71 | 4.27 | 27.61 | 0.79 | 6.76 | 71.74 | 2.22 | -13.75 | -51.91 | 4.00 | -11.96 | -29.59 | 1.85 | -9.86 | -5.25 | 2227 | 0.0 | 17.03 |
| 24Q2 (19) | 36.07 | 30.08 | 43.48 | 0.93 | 3.33 | 17.72 | 1.64 | 8.61 | 28.12 | 0.74 | 45.1 | 54.17 | 2.58 | -20.56 | -17.95 | 4.55 | -16.5 | -10.7 | 2.05 | 11.55 | 7.45 | 2227 | 0.0 | 17.03 |
| 24Q1 (18) | 27.73 | -41.36 | 68.37 | 0.9 | -12.62 | 28.57 | 1.51 | -24.88 | 36.04 | 0.51 | -25.0 | 27.5 | 3.25 | 49.01 | -23.64 | 5.45 | 28.12 | -19.2 | 1.84 | 27.9 | -24.27 | 2227 | 0.0 | 17.03 |
| 23Q4 (17) | 47.29 | 100.64 | 77.98 | 1.03 | -5.5 | 30.38 | 2.01 | 50.0 | 71.79 | 0.68 | 47.83 | 54.55 | 2.18 | -52.9 | -26.75 | 4.25 | -25.24 | -3.48 | 1.44 | -26.32 | -13.17 | 2227 | 17.03 | 17.03 |
| 23Q3 (16) | 23.57 | -6.25 | -22.21 | 1.09 | 37.97 | 34.57 | 1.34 | 4.69 | -2.9 | 0.46 | -4.17 | -14.81 | 4.62 | 47.17 | 72.99 | 5.69 | 11.66 | 24.83 | 1.95 | 2.22 | 9.51 | 1903 | 0.0 | -4.99 |
| 23Q2 (15) | 25.14 | 52.64 | -9.63 | 0.79 | 12.86 | 5.33 | 1.28 | 15.32 | 8.47 | 0.48 | 20.0 | 4.35 | 3.14 | -26.06 | 16.56 | 5.09 | -24.45 | 20.04 | 1.91 | -21.38 | 15.47 | 1903 | 0.0 | -4.99 |
| 23Q1 (14) | 16.47 | -38.01 | -21.16 | 0.7 | -11.39 | -2.78 | 1.11 | -5.13 | 0.0 | 0.4 | -9.09 | -6.98 | 4.25 | 42.94 | 23.31 | 6.74 | 53.05 | 26.84 | 2.43 | 46.66 | 17.99 | 1903 | 0.0 | -4.99 |
| 22Q4 (13) | 26.57 | -12.31 | 1.41 | 0.79 | -2.47 | -14.13 | 1.17 | -15.22 | -4.1 | 0.44 | -18.52 | -4.35 | 2.97 | 11.22 | -15.33 | 4.40 | -3.32 | -5.43 | 1.66 | -7.08 | -5.68 | 1903 | -4.99 | -4.99 |
| 22Q3 (12) | 30.3 | 8.91 | 14.51 | 0.81 | 8.0 | -2.41 | 1.38 | 16.95 | 20.0 | 0.54 | 17.39 | 3.85 | 2.67 | -0.84 | -14.78 | 4.55 | 7.38 | 4.79 | 1.78 | 7.78 | -9.31 | 2003 | 0.0 | -8.5 |
| 22Q2 (11) | 27.82 | 33.17 | 18.99 | 0.75 | 4.17 | 2.74 | 1.18 | 6.31 | 21.65 | 0.46 | 6.98 | -13.21 | 2.70 | -21.78 | -13.66 | 4.24 | -20.17 | 2.23 | 1.65 | -19.67 | -27.06 | 2003 | 0.0 | -8.5 |
| 22Q1 (10) | 20.89 | -20.27 | 14.84 | 0.72 | -21.74 | -4.0 | 1.11 | -9.02 | 11.0 | 0.43 | -6.52 | -18.87 | 3.45 | -1.85 | -16.41 | 5.31 | 14.11 | -3.35 | 2.06 | 17.24 | -29.35 | 2003 | 0.0 | -8.5 |
| 21Q4 (9) | 26.2 | -0.98 | 38.26 | 0.92 | 10.84 | 24.32 | 1.22 | 6.09 | 7.96 | 0.46 | -11.54 | -23.33 | 3.51 | 11.94 | -10.08 | 4.66 | 7.14 | -21.91 | 1.76 | -10.66 | -44.55 | 2003 | -8.5 | -8.5 |
| 21Q3 (8) | 26.46 | 13.17 | 25.17 | 0.83 | 13.7 | -1.19 | 1.15 | 18.56 | 8.49 | 0.52 | -1.89 | -16.13 | 3.14 | 0.46 | -21.06 | 4.35 | 4.76 | -13.32 | 1.97 | -13.31 | -32.99 | 2189 | 0.0 | 1.96 |
| 21Q2 (7) | 23.38 | 28.53 | 6.32 | 0.73 | -2.67 | -6.41 | 0.97 | -3.0 | -13.39 | 0.53 | 0.0 | -5.36 | 3.12 | -24.27 | -11.97 | 4.15 | -24.53 | -18.54 | 2.27 | -22.2 | -10.98 | 2189 | 0.0 | 1.96 |
| 21Q1 (6) | 18.19 | -4.01 | 36.05 | 0.75 | 1.35 | -1.32 | 1.0 | -11.5 | 2.04 | 0.53 | -11.67 | 12.77 | 4.12 | 5.59 | -27.47 | 5.50 | -7.81 | -25.0 | 2.91 | -7.98 | -17.11 | 2189 | 0.0 | 7.89 |
| 20Q4 (5) | 18.95 | -10.36 | -8.37 | 0.74 | -11.9 | -20.43 | 1.13 | 6.6 | -12.4 | 0.6 | -3.23 | -16.67 | 3.91 | -1.72 | -13.17 | 5.96 | 18.92 | -4.41 | 3.17 | 7.96 | -9.06 | 2189 | 1.96 | 7.89 |
| 20Q3 (4) | 21.14 | -3.87 | 0.0 | 0.84 | 7.69 | 0.0 | 1.06 | -5.36 | 0.0 | 0.62 | 10.71 | 0.0 | 3.97 | 12.02 | 0.0 | 5.01 | -1.55 | 0.0 | 2.93 | 15.17 | 0.0 | 2147 | 0.0 | 0.0 |
| 20Q2 (3) | 21.99 | 64.47 | 0.0 | 0.78 | 2.63 | 0.0 | 1.12 | 14.29 | 0.0 | 0.56 | 19.15 | 0.0 | 3.55 | -37.6 | 0.0 | 5.09 | -30.51 | 0.0 | 2.55 | -27.56 | 0.0 | 2147 | 5.82 | 0.0 |
| 20Q1 (2) | 13.37 | -35.35 | 0.0 | 0.76 | -18.28 | 0.0 | 0.98 | -24.03 | 0.0 | 0.47 | -34.72 | 0.0 | 5.68 | 26.4 | 0.0 | 7.33 | 17.5 | 0.0 | 3.52 | 0.97 | 0.0 | 2029 | 0.0 | 0.0 |
| 19Q4 (1) | 20.68 | 0.0 | 0.0 | 0.93 | 0.0 | 0.0 | 1.29 | 0.0 | 0.0 | 0.72 | 0.0 | 0.0 | 4.50 | 0.0 | 0.0 | 6.24 | 0.0 | 0.0 | 3.48 | 0.0 | 0.0 | 2029 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 112.47 | 6.53 | 3.62 | 17.53 | 5.75 | 18.8 | 2.02 | 8.02 | 3.22 | 10.33 | 5.11 | 11.52 | 1.80 | 1.4 | 1903 | 0.0 |
| 2022 (9) | 105.58 | 12.04 | 3.08 | -4.94 | 4.84 | 11.78 | 1.87 | -8.33 | 2.92 | -15.16 | 4.58 | -0.24 | 1.77 | -18.19 | 1903 | -4.99 |
| 2021 (8) | 94.23 | 24.89 | 3.24 | 3.85 | 4.33 | 0.93 | 2.04 | -9.73 | 3.44 | -16.85 | 4.60 | -19.18 | 2.16 | -27.72 | 2003 | -8.5 |
| 2020 (7) | 75.45 | 10.39 | 3.12 | -7.96 | 4.29 | 6.98 | 2.26 | -0.44 | 4.14 | -16.63 | 5.69 | -3.08 | 3.00 | -9.81 | 2189 | 1.96 |
| 2019 (6) | 68.35 | 4.82 | 3.39 | -2.59 | 4.01 | 17.6 | 2.27 | 12.38 | 4.96 | -7.06 | 5.87 | 12.19 | 3.32 | 7.21 | 2147 | 5.82 |
| 2018 (5) | 65.21 | 18.26 | 3.48 | 17.97 | 3.41 | 8.95 | 2.02 | 13.48 | 5.34 | -0.25 | 5.23 | -7.88 | 3.10 | -4.04 | 2029 | -2.69 |
| 2017 (4) | 55.14 | 5.83 | 2.95 | -4.53 | 3.13 | 9.82 | 1.78 | 0.0 | 5.35 | -9.79 | 5.68 | 3.77 | 3.23 | -5.51 | 2085 | 13.13 |
| 2016 (3) | 52.1 | 17.37 | 3.09 | 20.7 | 2.85 | 2.15 | 1.78 | 9.88 | 5.93 | 2.84 | 5.47 | -12.97 | 3.42 | -6.38 | 1843 | 14.76 |
| 2015 (2) | 44.39 | -0.76 | 2.56 | -7.58 | 2.79 | -1.41 | 1.62 | 7.28 | 5.77 | -6.87 | 6.29 | -0.66 | 3.65 | 8.11 | 1606 | 6.92 |
| 2014 (1) | 44.73 | 20.11 | 2.77 | 19.4 | 2.83 | 3.28 | 1.51 | 24.79 | 6.19 | 0 | 6.33 | 0 | 3.38 | 0 | 1502 | -14.51 |
